Search Results - Craze, Madeleine

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Altered glutamine metabolism in breast cancer: subtype dependencies and alternative adaptations

    Altered glutamine metabolism in breast cancer: subtype dependencies and alternative adaptations by El Ansari, Rokaya, McIntyre, Alan, Craze, Madeleine L., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.

    Published 2017
    Get full text
  2. 2
    FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype

    FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype by Joseph, C., Craze, Madeleine L., Nolan, C.C., Diez-Rodriguez, Maria, Green, Andrew R., Rakha, Emad, Ellis, Ian O., Mukherjee, A.

    Published 2017
    Get full text
  3. 3
    The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes

    The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes by El Ansari, Rokaya, Craze, Madeleine L., Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad A., Green, Andrew R.

    Published 2018
    Get full text
  4. 4
    The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours

    The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours by El Ansari, Rokaya, Craze, Madeleine L., Miligy, Islam, Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad, Green, Andrew R.

    Published 2018
    Get full text
  5. 5
    Phenotypic characterization of breast cancer: the role of CDC42

    Phenotypic characterization of breast cancer: the role of CDC42 by Chrysanthou, Eleni, Gorringe, Kylie L., Joseph, Chitra, Craze, Madeleine L., Nolan, Christopher C., Diez-Rodriguez, Maria, Green, Andrew R., Rakha, Emad A., Ellis, Ian O., Mukherjee, Abhik

    Published 2017
    Get full text
  6. 6
    Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes

    Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes by Joseph, Chitra, Macnamara, Olivia, Craze, Madeleine, Russell, Roslin, Provenzano, Elena, Nolan, Christopher C., Diez-Rodriguez, Maria, Sonbul, Sultan N., Aleskandarany, Mohammed A., Green, Andrew R., Rakha, Emad A., Ellis, Ian O., Mukherjee, Abhik

    Published 2018
    Get full text
  7. 7
    MYC regulation of Glutamine-Proline regulatory axis is key in Luminal B breast cancer

    MYC regulation of Glutamine-Proline regulatory axis is key in Luminal B breast cancer by Craze, Madeleine L., Cheung, Hayley, Jewa, Natasha, Coimbra, Nuno D.M., Soria, Daniele, El-Ansari, Rokaya, Aleskandarany, Mohammed A., Cheng, Kiu Wai, Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad, Green, Andrew R.

    Published 2017
    Get full text
  8. 8
    Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic markers in non-small cell lung cancer

    Multicomponent analysis of the tumour microenvironment reveals low CD8 T cell number, low stromal caveolin-1 and high tenascin-C and their combination as significant prognostic mar... by Onion, David, Isherwood, Mark, Shridhar, Naveen, Xenophontos, Mikalena, Craze, Madeleine L., Day, Laura J., Gárcia-Marquez, Maria A., Pineda, Robert G., Reece-Smith, Alex M., Saunders, John H., Duffy, John P., Argent, Richard H., Grabowska, Anna M.

    Published 2017
    Get full text
  9. 9
    3-dimensional patient-derived lung cancer assays reveal resistance to standards-of-care promoted by stromal cells but sensitivity to histone deacetylase inhibitors

    3-dimensional patient-derived lung cancer assays reveal resistance to standards-of-care promoted by stromal cells but sensitivity to histone deacetylase inhibitors by Onion, David, Argent, Richard H., Reece-Smith, Alex M., Craze, Madeleine L., Pineda, Robert G., Clarke, Philip A., Ratan, Hari L., Parsons, Simon L., Lobo, Dileep N., Duffy, John P., Atherton, John C., McKenzie, Andrew J., Kumari, Rajendra, King, Peter, Hall, Brett M., Grabowska, Anna M.

    Published 2016
    Get full text

Search Tools: